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Available online 15 March 2011Muscle represents a large fraction of the human body mass. It is an extremely
heterogeneous tissue featuring in its contractile structure various proportions of heavy-
and light-chain slow type 1 and fast types 2A and 2X myosins, actins, tropomyosins, and
troponin complexes as well as metabolic proteins (enzymes and most of the players of the
so-called excitation–transcription coupling). Muscle is characterized by wide plasticity, i.e.
capacity to adjust size and functional properties in response to endogenous and exogenous
influences. Over the last decade, proteomics has become a crucial technique for the
assessment of muscle at the molecular level and the investigation of its functional changes.
Advantages and shortcomings of recent techniques for muscle proteome analysis are
discussed. Data from differential proteomics applied to healthy individuals in normal and
unusual environments (hypoxia and cold), in exercise, immobilization, aging and to patients
with neuromuscular hereditary disorders (NMDs), inclusion body myositis and insulin
resistance are summarized, critically discussed and, when required, compared with
homologous data from pertinent animal models. The advantages as well as the limits of
proteomics in view of the identification of new biomarkers are evaluated.
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The “plasticity” of skeletalmuscle is the capacity to adjust size
and functional properties of its fibers in response to endog-
enous and exogenous influences. Among the latter, the most
effective are neural input as shown originally, in the cat, by
Buller et al. [1] with the classic nerve cross-union experiments,
mechanical loading, such as during resistance and endurance
exercise and various other training protocols, inactivity, such
as in forced bed rest, exposure to unusual environmental
conditions (hypo- and hypergravity, cold and hypoxia), aging
and the effects of a number of biochemical, trophic and hormonal
variables [2,3]. Adaptive features, mainly mediated by altered
gene expression but also by post-translational modifications,
may result in species-specific changes of contractile, meta-
bolic and signaling protein patterns as shown by recent
findings of muscle proteomics, from small rodents (mouse and
rat) to humans. The present work is aimed at analyzing the
results of muscle proteomics work carried out in human
subjects: 1) In physiological and paraphysiological conditions
(hypoxia, cold and overfeeding, exercise training, aging and
immobilization). In this context, a special effort was made to
extend the analysis to different muscles (soleus, gastrocne-
mius and deltoideus, within and between subjects) besides the
vastus lateralis which has been, by far, the most investigated
tissue for ultrastructural, biochemical and proteomics re-
search; 2) In patients affected by various pathologic conditions
such as neuromuscular hereditary disorders (NMDs) and type
2 diabetes. In addition, whenever possible, similarities or
differences between results from human and animal proteo-
mics studies have been outlined, with particular emphasis
placed on the effects of hypoxia, exercise and training,
immobilization and aging.2. Some aspects of the plasticity of human
muscle fibers
2.1. Myosin heavy chain (MHC) isoforms and changes of
MHC expression
As is well known, myosin is the most abundant protein
expressed in striated muscle fibrocells, i.e., ~25% of their total
protein pool. The myosin molecule is a hexamere featuring
two heavy chains (molecular mass of 22 kDa each) whose
carboxy-terminal portions form an α-helical coiled-coil rod
(the “tail”) whereas the two separated amino-terminal por-
tions form two elongated globular domains (the “heads”). Each
“head” comprises the S1 subfragment of the heavy chain (the
“neck”) and contains a catalytic site for binding and hydro-
lyzing ATP as well as a site for binding actin in the thin
filament: Each “neck” is associated with two non-identical
pairs of myosin light chains, the “essential” ELC or “alkali”
25 kDa, MLC 1 and the “regulatory” RLC or “phosphorylatable”
20 kDa, MLC 2 (Fig. 1). Both MHCs and MLCs exist in several
isoforms in different fiber types and are the product of three
multigene families, presumably derived froma single ancestor
gene. TheMHC family comprises several genes, each encoding
a distinct isoform. Since the MHC gene family is sensitive to
mechanical and hormonal stimuli, it will serve as a cellular
“marker” for muscle plasticity and adaptive responses [4]. At
least 10 MHC isoforms produced by distinct genes have been
identified inmammalian striated (heart and skeletal)muscles:
1) embryonic; 2) neonatal; 3) cardiac α; 4) cardiac β or slow type
1, as expressed by the same gene, particularly in adult slow
skeletal muscles; 5) fast 2A; 6) fast 2X/2D; 7) fast 2B; 8)
extraocular; 9) mandibular or masticatory (m-MHC) and 10)
the slow tonic MHC. In addition to type 1 MHC, adult skeletal
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Fig. 1 – Schematic representation of the myosin molecule.
Myosin is a hexamere featuring two heavy chains, each one
characterized by three different regions: tail, neck and head.
Moreover, each neck is associated to two non-identical pairs
of myosin light chains (essential and regulatory,
respectively).
Fig. 2 – Thin filament structure. In the thin filaments of
muscle, actin, tropomyosin, troponin I, troponin C, and
troponin T are arranged regularly to form a protein complex.muscles express in humans various proportions of fast-type 2A
and 2XMHC whereas type 2B is not detected, at variance with
its transcript [5]. In humans, the cardiac slow α and β genes are
located on chromosome 14, whereas the other genes, includ-
ing the adult fast MHC 2A and 2X, are found on chromosome
17 in a relative tight cluster. Thick filaments in mammalian
striated muscles are composed of ~600 myosin molecules
whose “tails” point toward the center of the sarcomere (the
myofiber functional unit) whereas the “heads” protrude from
the filament every 60° for binding with actin. Myosin, the
motor protein, is a mechanical–chemical enzyme converting,
via ATP-ase activity, chemical into mechanical energy and
represents the molecular basis for force generation and
contractile function. The contractile properties of striated
muscles are imposed mainly by the pattern of myosin heavy
chain isoforms expressed in the fibers. For almost half a
century, skeletal muscle fibers appeared to cluster into similar
groups of cells with each fiber being innervated by the same
motor neuron (motor unit), the latter being characterized by
the same histochemical staining for ATP-ase and by common
biochemical and physiological properties. Over the last two
decades, the composition of individual fibers was accurately
assessed by means of immuno-histochemical techniques or,
alternatively, of gel electrophoresis to separate the MHC
isoforms. The results show that single fibers can express
more than one MHC isoforms [6–9]. Thus, fibers from
mammals were found to contain variable proportions of
MHC hybrids coexpressing, at the protein level, up to four
isoforms [10]. This makes up the spectrum of various motor
units and sheds light on the plasticity of expression of the
MHC gene family as well as on its regulation. Indeed, skeletal
muscle fibers are elongated multinucleated cells containing a
very large number of myonuclei, each controlling protein
synthesis within its surrounding cytoplasm, constituting a
series of myonuclear domains that, responding to localized
signals, may result in differential gene expression along the
fiber [11]. The fraction of hybrid fibers in the vastus lateralis
muscle of normal young adults is ~6% for both types 1+2A and
type A+2X andnone of the fibers containsmore than twoMHCisoforms [12]. Differences between muscles and species-
specific variants were also found [11].
2.2. Myosin light chain polymorphism
As indicated earlier, in each muscle myosin molecule, MLCs
consist of a pair of essential light chains (MLC 1 and/or MLC 3)
and of a pair of regulatory light chains (in skeletal muscle, MLC
2) that are non-covalently associated with theMHC at the base
of the “neck” segment. All vertebrates express a specific
subfamily of essential and regulatory isoforms in their skeletal
muscles in combination with MHC isoforms. Skeletal muscle
type 1 slow fibers express MHC 1 together with a slow isoform
of essential MLC (MLC 1 s) and of a regulatory MLC (MLC 2 s)
light chain, respectively; in fast fibers, MHC isoforms are
associated with two distinct isoforms of essential (MLC 1f or
MLC 3f, originating from a single gene) and one isoform of
regulatory MLC 2f light chains. Each MLC is coded by distinct
genes dispersed in different chromosomes. In a given species,
changing associations of various MHC and MLC isoforms,
generate populations of muscle fibers with a large range of
specific functional properties. Stevens et al. have shown in the
rat soleus that the MHC type 2 vs type 1 ratio varied in parallel
to the fast to slow ratio of regulatory and essential MLC
isoforms [13]. In human skeletal muscles it has been
established that MLC isoforms, in association with MHC,
influence maximum shortening velocity [14]. MHC isoforms
are themain determinant of myosin ATP-ase activity whereas
the ELC isoforms play a significant regulatory role when ATP-
ase activity is determined at low ionic strength [15].
Since muscle adaptation involves changes in myosin
isoform composition and the latter controls contractile
muscle function, it is expected that muscle adaptation will
also change the contractile function. Particularly in transform-
ing muscles, hybrid fibers could contribute to the functional
plasticity of muscles by rapidly changing functional para-
meters such as Vmax, the tension/pCa2+ relationship and
maximal force [11].
2.3. Thin filament myofibrillar proteins
As shown in Fig. 2, actin is a globular protein (G actin,
molecular mass of ~43 kDa) that polymerizes forming actin F
filaments representing the backbone of the thin filament with
a two-stranded long-pitch helical structure. Ca2+ regulates
interactions betweenmyosin and actin via tropomyosins (Tm)
and the troponin (Tn) complex. Actin comprises ~20% of
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Fig. 3 – Excitation–transcription coupling. The figure shows a
series of intracellular signaling circuits and of transcription
factors and co-factors controlling muscle gene expression.
Among these factors are the reactions triggered by
calcineurin and Ca2+/calmodulin-dependent protein kinase
(CaMK), the pathway triggered by muscle contraction
(PKB/Akt) and metabolic changes (AMPK).myofibrillar proteins and 12% of total proteins in skeletal
muscle [16]. Each actin monomer comprises four subdomains:
the smaller ones, 1 and 2, are located at the periphery of the
filament (outside of the helix) interacting with myosin by
means of NH2 and COOH termini; subdomains 3 and 4 are
close to the helix axis and interact with homologous
subdomains of other actin monomers. There are two sarco-
meric actin isoforms, α-skeletal and α-cardiac actins, each
variant being coded by a distinct gene, differing only by 4
substitutions highly conserved during vertebrate evolution.
Functional features of actin depend on its level of expression
and not on isoform changes. Loss of weight-bearing function
causes skeletal muscle atrophy which, at the protein level, is
characterized by a higher loss of actin thin filaments than
myosin thick filaments [17]. This structural change of the
sarcomere causes earlier cross-bridge detachment and faster
cycling andmay explain the increase of fiber 1 and 2A velocity
of shortening after exposure to microgravity. Myofiber hyper-
trophy induced by heavy leg resistance-exercise does not
affect human α-skeletal actin expression [18].
2.4. Muscle contractile protein-induced post-translational
changes
Post-translational modifications can induce altered modula-
tion in the activity of proteins involved in muscle contraction
as well as dysregulation of metabolic functions. Regulatory
muscle light chains (MLC 2) feature sites suitable for phos-
phorylation thereby altering the control of myosin–actin
interaction, e.g. by increasing Ca2+ sensitivity of the fiber. A
clear correlation could be observed between increased MLC 2
phosphorylation and slow-to-fast phenotype transition [11].
The role of phosphorylation of α- and β-tropomyosins in adult
humans remains under discussion as are the effects of post-
translational modifications of troponin. Regarding glycosyla-
tion of muscle proteins, the role of such post-translational
change in the regulation of muscle function has not been
considered yet [19].
2.5. Signaling molecules in pathways controlling muscle
fiber size and type
Muscle hypertrophy and atrophy and the switching of fibers
from fast to slow phenotypes and vice-versa are largely induced
by the pattern of nerve activity and by the mechanical load
imposed on the tissue and have, as outcome, changes of force
generation, speed of shortening and resistance to fatigue.
Among the factors mediating the effects of nerve stimulation
are a series of intracellular signaling circuits and of transcription
factors and co-factors controlling muscle gene expression, i.e.
the players of the so-called excitation–transcription coupling [20]
which likely involve a variety of pathways triggered by various
steps along the excitation–contraction coupling and the complex
pathways of post-contraction events. Among these, the reac-
tions triggered by calcineurin and Ca2+/calmodulin-dependent
protein kinase (CaMK), the pathway triggered by muscle
contraction (e.g. PKB/Akt) and those elicited by metabolic
changes (e.g., AMPK) shown to affect muscle fiber size and
type (Fig. 3). Genetic approaches to either, block or stimulate
specific signaling pathways, and have been adopted in both invitro and in vivo experimental models. By means of in vivo
models, the above authors were able to describe the function of
the Ras-ERK and calcineurin-NFAT pathways in the induction
andmaintenance of the slowphenotype aswell as the role of the
Akt-mTOR and Akt-FOX-O pathways in muscle atrophy and
hypertrophy [21]. More recently, several players of metabolic
signaling pathways started being investigated by differential
proteomics and could be correlated with upstream regulators of
muscle function.3. The contribution of proteomics to the study
of human muscle
3.1. The systematic definition of “muscle proteome”
After up-dating basic notions of myofibrillar protein ultrastruc-
ture and of muscle plasticity and shortly outlining some of the
signaling pathways known to control activity-dependent fiber
responses, we shall describe the contributions made so far by
proteomics in the study of skeletal muscle. Particular emphasis
is laid on the identification of datasets of proteins potentially
detectable in humanmuscle, thereby providing the background
for the comprehension of unknown paraphysiological and
physiopathological mechanisms affecting its function.
After the pioneeringwork of Giometti andAnderson [22–24]
investigations on human muscle proteome, also including
post translational modifications, were resumed with a study
whereby ~500 protein spots of the vastus lateralis muscle
from a pool of healthy Asian subjects were separated by two-
dimensional gel electrophoresis (2DE) [25]. Gels were silver
stained adopting the protocol of Yan et al. [26] and spots
manually excised. 124 spots were identified by MALDI-ToF MS
and HPLC–ESI–MS/MS. Among these, several myofibrillar
contractile proteins were found, including myosin light-
chain 1 and 2 isoforms, actins, α-chain tropomyosin, troponin
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of enzymes involved in glycolytic and aerobic metabolism.
From this work, it appeared that the wide distribution of
protein spots within 2D gels, due to the high dynamic range of
muscle tissue, might affect the detection of the less abundant
molecules, hence the need for additional, more specific
separation steps in different pH ranges. Indeed, the distribu-
tion of contractile proteins in 2Dmaps was not homogeneous,
with the most abundant spots being concentrated within the
acidic range whereas a large number of regulatory proteins
were located in the alkaline region of the gel (Fig. 4). Moreover,
despite the high separative power of 2DE, a consistent number
of contractile proteins characterized by highmolecular weight
(e.g. titin, nebulin, and MHC), hydrophobic molecules and
proteins with very alkaline pI could not be separated.
Conversely, the 2DE technology presented some advantages
for muscle proteomic analysis, particularly for its capability of
separating isoforms, i.e. crucial elements for the muscle
functional assessment.
Before describing the most recent technical advances that
follow the preliminary investigation in systematic muscle
proteomics, two important issues must be raised, i.e. that of
the high tissue composition variability (intra- and inter-
individual, within muscles and even fibers) and that of tissue
plasticity, the latter expected to potentially influence the
reproducibility of most experimental findings. Even though
muscle protein characterizationwas initially carried out by twoFig. 4 – Vastus lateralismuscle 2-DEmap. Proteins were separated
(12% T, 2.5% C) in the second dimension and gel was silver staine
UniProt KB entries.dimensional gel electrophoresis (2DE), due to its limitations to
provide a global view of the muscle proteome, it was necessary
to combine alternative technologies. In this context, different
muscle characterizations were attempted by the use of shotgun
proteomics [27], a technique developed for identifying proteins in
complex mixtures using a combination of HPLC and mass
spectrometry. In principle, this technology can overcome the
limitations imposed by 2D electrophoresis. In fact, the latter is
able to cope with the dynamic range of muscle proteome, but
the sensitivity of hyphenated analytical techniques, combined
with advancement in mass spectrometry resolution, remains
incomparable, considering the possibility of using solubilizing
agents that are compatible with the separative steps adopted
prior to MS analysis. In earlier studies, the samples were
digested by specific proteases (usually trypsin) and the peptides
were separated and analyzed bymass spectrometry. Themajor
disadvantage of this method is that nearly all protein isoform-
specific information is lost [28]. In 2008, Hojlund et al. analyzed
human vastus lateralis muscle by combining a fractionation by
one-dimensional gel electrophoresis and subsequent HPLC–ESI
MS/MS of lysates of 20–24 SDS gel slices digested with trypsin
[29]. This approach allowed identification in 3 healthy subjects
of a total of 954 different proteins comprising a large number of
contractile molecules and most of the enzymes involved in the
major pathways of glucose and lipid metabolism with a large
share of mitochondrial enzymes. However, only 446 molecules
were common to all investigated subjects introducing the issueusing IPG pH 3–10 NL strip in the first dimension and SDS gel
d. Proteins identified are indicated by circles and namedwith
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reproducibility rate of two replicates made on the same sample
for one of the subjects was found to be 75%. As expected, the
three major isoforms of MHC accounted for 42% of the total
spectra. Therefore, the analytical volume taken by this
abundant protein, presumably hampers the identification of
less abundant proteins that co-migrate in the same gel region.
By adopting sample pre-fractionation in a linear gradient of
acrylamide (4–20% T), the proportion of spectra accounting for
MHC isoforms dropped to 32%. Apart from the inter-individual
variability, this study also highlighted the presence of isoforms
of the same proteins which are crucial muscle functional
regulators. Themajority of proteins presented a single IPI Id but
230 of them were characterized by two associated Ids and 162
had more than two. Of the identified proteins (776 out of 954),
59% could be assigned to the cytoplasm, 22% to the mitochon-
dria, whereas 17% were nuclear proteins. Broad proteomics
coverage was shown of themajor enzymes involved, e.g., in the
phosphocreatine/creatine pool, i.e., the major source of energy
phosphate bonds for ATP resynthesis in response to muscle
contraction; in Ca2+ homeostasis, including three members of
the voltage-dependent Ca2+-channel complex, ryanodine re-
ceptor 1, calmodulin, and several Ca2+-binding or regulated
proteins such as calcineurin A and protein Kinase II; in glycogen
metabolism; in the glycolytic pathway; in the citric acid cycle; in
fatty acid transport and oxidation, as well as in oxidative
phosphorylation. This methodological approach allowed defi-
nition of proteins that were out of the 2DE resolution range by
also classifying 114 proteins of over 100 kDa and 11 with MWof
less than 10 kDa. Interestingly, proteins were grouped into theFig. 5 – Structure of sarcomere. Proteins identified by Hojlund et
HPLC–ESI–MS/MS, are indicated into a representative scheme ofmajor pathways known to regulate muscle function such as
glucose and lipid metabolism, electron transport and oxidative
phosphorylation, calcium homeostasis, myofibrillar apparatus
and components of IGF and insulin signaling, providing a
comprehensive functional picture of the muscle proteome.
Fig. 5 features the contractile proteins identified by this
approach into a representative scheme of the sarcomere.
Thus it would appear that the majority of contractile proteins
can be identified by combining different proteomic methodol-
ogies thereby suggesting the possibility of optimizing proteome
definition. The same authors [30] conducted a parallel study of
gene expression profiles and proteome analysis on healthy
individuals by combining the Affymetrix platform with the
proteomic pipeline described above. Among the 5193 identified
transcripts, 437 had their corresponding protein detected by
mass spectrometry. Unfortunately, the gene expression profile
was obtained from subjects that were different from those
participating in the proteomic study. This could be one of the
causes of the reduced overlap between gene products and
proteins. However, even when both proteome and transcrip-
tome were obtained from the same subject, only a slightly
increased homology was observed raising a number of issues
related to the significance and the interpretation of the results
of these comparative studies. Apart from the use of different
subjects and from the intrinsic variability of muscle tissue,
unlike sensitivity and the different principles at the basis of the
two technologies (unbiased vs biased analyses), have to be
taken into account. The advantage of combining these powerful
technologies is not only to verify the existence of overlapping
results, but to complement gene expression profile withal., combining one dimensional gel electrophoresis and
the sarcomere.
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Fig. 6 – Phosphorylation distribution. Pie chart shows the
number of phosphorylation sites localized in various muscle
functional compartments and pathways.proteomic data. It is also noteworthy that, when combined
analyses of gene transcripts and proteins are planned, experi-
ments should be performed on the same samples in order to
increase the information provided by the two separated “omic”
analyses. This joint approach generates anoverall picture of the
muscle thereby opening new avenues for evaluating the
significance of muscle diversity in physiological and patholog-
ical conditions [31].
Recently, using four differentworkflows (1D and 2D peptide
separation, SDS gels and differential solubilization), 2000
proteins were identified from samples of unspecified muscles
obtained from 31 patients affected by a wide range of muscle
diseases, particularly inflammatory myopathies, and from
other patients that did not have muscle disorders [32]. A large
number of proteins involved in muscle function were identi-
fied whereas differences between various muscles and/or
subjects were not taken into account. The authors by using
shotgun proteomics propose a list of candidates for the major
structural components of the sarcomere. In this paper, two
distinct technologies were compared, i.e., SDS gel-based
protein fractionation followed by peptide digestion and 2D
peptide separation. It would appear that the former is more
efficient in terms of identification of proteins than the latter.
In fact, sarcomeric proteins are lost when adopting 2D peptide
separation in which the dynamic range of the sample is
greater than allowed by the performances of the mass
spectrometer. Conversely, in digested SDS samples, the most
abundant proteins were confined to 2 or 3 slices, thereby
increasing the detectability of the less abundant species.What
should be pointed out is that the plasticity of muscle tissue is
not taken into account as was the reproducibility of the data
between various subjects or patients. In fact, proteins are
considered when found in 2 out of 3 individuals.
3.2. Post-translational modifications
These changes represent an important issue to be faced in
systematic and functional proteomic studies. Among others,
phosphorylation represents a key regulatory mechanism
controlling the activity of enzymes playing a crucial role in
signal transduction pathways regulating energy metabolism,
excitation–contraction coupling, sarcomeric function, muscle
mass balance and fiber type distribution in relation to
mechanical stress, inflammatory factors and hormones
[33–35]. A number of hypothesis-driven studies have been
conducted by analyzing phosphorylation of specific proteins
along signaling pathways forwhich antibodies recognizing the
phospho-epitope were available. To fill this gap, a phospho-
proteome assessment after phosphopeptide enrichment by
SCX and TiO2 by HPLC–ESI MS/MS from 3 to 5 mg of muscle
protein extracts of 30–50 mg of tissue samples obtained by
surgical biopsies from the vastus lateralis muscle of 3 lean,
healthy volunteers was performed [36]. In total the authors
could identify 367 phosphorylation sites (phosphotyrosine,
phosphoserine, phosphothreonine) in 144 proteins from at
least 2 out of 3 subjects. As a result, after phosphopeptide
enrichment, ~35% of the identified proteins were phospho-
proteins. Fig. 6 shows the number of phosphorylation sites
localized in the various muscle functional compartments.
These results provide possible targets of phosphorylationsignaling for the investigation of human skeletal muscle in
health and disease. In any case, further studies are needed to
fully understand the functional significance of these sites.
3.3. The proteomic profile of functional mitochondria
Special emphasis shall also be placed on the study of human
skeletal muscle mitochondria for the possible assessment of
proteins from small samples of healthy and diseased skeletal
muscles [37,38]. In the above investigation, 100 mg of tissue
biopsies were utilized for mitochondrial enrichment. With this
amount of tissue, the authors could perform both functional
and proteome characterizations of muscle mitochondria. The
mitochondrial enriched fractions from healthy individuals
were separated by 1D SDS and HPLC ESI MS/MS as previously
described for skeletal muscle. As mentioned before, a combi-
nation of methodologies appeared to be the appropriate choice
for systematic studies on a restricted number of subjects, since
it provided an exhaustive list of proteins expressed in a specific
cellular compartment. In this case, results obtained from 4
healthy subjects provided different datasets and, by compari-
son and elimination of redundancies, 823 uniqueproteins could
be identified of which 487 were assigned to the mitochondria.
This dataset is representative of a muscle extract enriched in
mitochondria in which muscle proteins are also present and
represent the most exhaustive list of mitochondrial muscle
proteins so far (Fig. 7). Recently, Zhao et al., combining different
phosphopeptide enrichment approaches with high perfor-
mance LC–MS/MS, presented the phosphorylation pattern of
isolated mitochondria from muscle of five healthy volunteers
[38]. The authors identified 155 distinct phosphorylation sites in
77 mitochondrial phosphoproteins.4. Differential studies under physiological and
paraphysiological conditions
A large section of the review shall be devoted to muscle
comparative proteomics with the aim of providing a global view
of the protein spectrum expressed in functionally different
muscles, in control conditions and at rest. The protein pattern
of a variety of homologous muscles from a large number of
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Fig. 7 – Oxidative phosphorylation pathway. Number of proteins identified by Lefort et al. in each complex is indicated in a
representative scheme of oxidative phosphorylation pathway.
(Modified from KEGG).healthy individuals, that is a pre-requisite for investigating
differential response to a set of age- and gender-dependent,
nutritional, exercise and environmental conditions, shall be
also presented and discussed. In addition, proteomic data
from pertinent animal models shall be outlined. The latter,
despite the diversity in muscle structures, fiber type distribu-
tion and metabolism, may represent useful tools for human
studies, particularly for the comprehension of specific molec-
ular mechanisms at the basis of adaptation to particular
experimental conditions and/or to disease. Until recently, the
muscle proteome was mainly assessed combining protein
separation by two-dimensional gel electrophoresis (2DE),
adopting the silver stain protocol and 2D-DIGE according to
Unlu et al. [39] and Tonge et al. [40], followed by protein
identification by MALDI-ToF MS and/or HPLC–ESI–MS/MS
analysis [25,41–45].
4.1. The proteome of muscle tissue under chronic and
subacute hypoxia
4.1.1. Chronic hypoxia
Based on the knowledge of their excellent exercise perfor-
mance at high altitude, the first study applying the proteomic
approach to a physiological investigation was aimed at
analyzing the differences in the vastus lateralis enzymatic
protein pattern between 9 high altitude Tibetan natives (Tib1)
shortly after a descent to moderate altitude, 6 second-
generation Tibetans (Tib2) born and living in Kathmandu
(1300 m a.s.l.) and never exposed to altitude before, and a
group of Nepali control subjects (N) native to moderate
altitude [42]. Investigated subjects were homogeneous for
age and gender. Muscle bioptic material was analyzed
adopting 2DE and ESI MS/MS for protein identification. The
aim was to correlate muscle functional features with possible
changes in the proteome. A restricted set of metabolic and
regulatory molecules (n=7, identified as: glutathione-S-trans-
ferase, Δ2-enoyl-CoA-hydratase, phosphoglycerate mutase,NADH-ubiquinone oxidoreductase and myoglobin, all in-
creased; lactate dehydrogenase, glyceraldehyde-3-phosphate
dehydrogenase, both decreased) was found to be changed by a
stringent statistical analysis. Some of the protein changes
found in altitude Sherpas were also present in Tib2. The
increased abundance of myoglobin isoforms observed in Tib1
sheds light on the possible alternative role of myoglobin as a
signaling molecule beside that of a classical oxygen store. It
should also be pointed out that the most abundant contractile
proteins were absent from this differential profile obtained by
comparing 500 spots, underlining the concept that an
adequate number of subjects, their homogeneity, together
with that of the sampling procedures, are essential features
for detecting actual alterations. A correlation of protein
changes with those of upstream markers of hypoxia assessed
by mRNA quantitation in Tib1, i.e., an increased expression of
HIF, eNOS and nNOS, was also found. In conclusion, muscle
proteomic analysis has highlighted some mechanisms by
which high altitude populations adapt to hypoxia, prevent
tissue damage from ROS, and optimize metabolic control,
thereby improving physical activity under extreme conditions.
The results of this study support the relevance of differential
proteomics for the analysis of muscle function.
4.1.2. Subacute hypoxia
The introduction of the 2D-DIGE technology [39,40] allowed a
step forward in muscle protein research, particularly in
physiological studies for which only a restricted number of
bioptic samples are usually available. In fact, the presence of
an internal standard with the co-migration of samples,
automated spot detection, powerful statistical analysis and,
last but not least, the high sensitivity of the method, allows
better detection of the changes in the protein pattern. The
method was applied successfully to the study of hypoxia
adaptation in healthy subjects. Muscle adaptative changes
occurring in the early phase of hypoxia exposure were
assessed in the vastus lateralis muscle of 10 young, physically
782 J O U R N A L O F P R O T E O M I C S 7 4 ( 2 0 1 1 ) 7 7 4 – 7 9 5
Fig. 8 – Quantitative distribution of contractile proteins.
Histogram shows the distribution of actins, MHC, MLC and
tropomyosins in vastus lateralis and deltoideus muscles.
Modified from Capitanio et al. [34].active Caucasians, before and after a 7–9 day-exposure to high
altitude during acclimatization to hypobaric hypoxia (Mar-
gherita Hut, Monte Rosa, 4559 m.) [46]. The results indicate
that proteins involved in iron transport, TCA cycle, oxidative
phosphorylation and oxidative stress response, assessed in
hypoxia at the end of altitude exposure, were significantly
decreased. In this study, hypoxia markers such as the hypoxia
inducible factor (HIF-1α) and pyruvate dehydrogenase kinase
(PDK1), after 7 to 9 days of exposure, were at the pre-hypoxia
levels, indicating that the early adaptive response to hypoxia
of human muscle does not involve the stabilization of HIF-1α.
Accordingly, the mammalian target of rapamycin (mTOR) was
also reduced, indicating that adaptation to hypoxia also
imposes a continuous control of muscle energy balance as
supported by the observed decrement of the translation
initiation factor 2α (eIF2α) involved in the control of protein
synthesis.
Animalmodels have been also adopted formuscle research
in hypoxia. Investigations on rat gastrocnemius muscle have
indicated [47] that a two week exposure to 10% oxygen
breathing, activates the HIF-1α gene program which includes
a decrement of TCA cycle and oxidative metabolism, and an
increment of glycolytic enzymes and deaminases involved in
ATP and AMP production. This coordinated metabolic re-
sponse is the result of an increment of PDK1 that shuttles the
pyruvate away from the generation of acetyl-CoA thereby
enhancing conversion to lactate (anaerobic glycolysis). Thus,
hypoxia adaptation differs from that of humans as outlined
above. However, it should be pointed out that the experimen-
tal protocols adopted for the human and animal experiments
referred to, cannot be compared, based on the species-specific
metabolic characteristics of the models. Indeed, the experi-
mental conditions in the rat could be considered similar to
that of a subchronic exposure for men, taking into account the
relatively greater fraction of life span affected by hypoxia.
Further investigations will be required to profile the proteome
modulation in rodents and other models (e.g. zebrafish) [48]
based on different exposure times and hypoxia levels in order
to make it possible the transfer of results to humans. These
findings could be of particular interest for the selection of
specificmolecular targets for prognosis or for pharmacological
interventions in diseases like COPD in which muscle adapta-
tion to hypoxia can facilitate a positive outcome [49]. The
described results underline the potential of differential
proteomics in providing new insight into the mechanisms of
adaptation to reduced O2 pressure in conditions in which
hypoxia is not the consequence of a disease. In the latter, in
fact, it will be difficult to discriminate disease-induced
changes from those by hypoxia “per se”.
4.2. Differential proteomics of muscles from the same
subject: Vastus lateralis vs deltoideus
The different individual protein expressions in human deltoi-
deus and vastus lateralis muscle of healthy sedentary subjects
were investigated by 2DE and ESI MS/MS [41]. These muscles
are characterized by similar ATP-ase-based fiber type distri-
bution [50] but differ ultrastructurally and metabolically [51].
Both have been extensively utilized for studies of muscle
plasticity. In the above investigation, low molecular weightcontractile protein isoforms compatible with the separative
range of 2D gels, were analyzed differentially, both qualita-
tively and quantitatively, by utilizing narrow pH gradients: pH
4–5 for troponin isoform assessment and pH 4.5–5.5 for MLC
isoforms. Several isoforms typical of fast and slow fibers were
detected and their quantitative expression was found to be
correlated with MHC isoform distribution, i.e., indirectly, with
fiber type distribution. However, the assessment of the MHC,
MLC and of the troponin pool of isoforms in muscle extracts
does not reveal anything about hybrid fibers which, as stated
in the Introduction of the review, may be present in most
muscles. Hybrid fibers are known to express isoforms that are
typical of fast and slow fibers even in different regions of the
same fiber [8,52]. Therefore, data obtained on muscle extracts
are informative only of the composition of the pool of fibers
present in a homogenized sample. The distribution of both
MLC and troponin was consistent with that of MHC (Fig. 8).
Apart from the characteristics of isoform distribution of some
contractile proteins, what appears relevant in this study is the
variety of metabolic proteins involved in glycolysis, TCA cycle,
oxidative phosphorylation and respiratory chain complexes.
These are more abundant in the vastus lateralis than in the
deltoideus, in line with the higher oxidative capacity of the
former. This finding is consistent with the functional role of
the vastus lateralis that is a locomotor and antigravity muscle
in constant use, whereas the deltoideus is unloaded for most
of the time. Also of note were the differences in isoforms of
some stress proteins, particularly peroxiredoxin and Hspb6.
For a more precise assessment of muscle plasticity and to
gain insight into the different responses to physiological,
paraphysiological and pathological stimuli of different mus-
cles, it would be essential to catalog proteins expressed in
isolated fast and/or slow fibers. As already highlighted in the
systematic section of this review, proteomics, particularly
when based on protein separation on 2D gels, fails to provide
the largest catalog of proteins expressed in a single fast or slow
fiber, due to the scarcity of material (few μg's of proteins
distributed in a large dynamic range). The analysis of whole
muscles with different fiber type compositions, such as the
soleus, that is prevalently oxidative, and the gastrocnemius
that is characterized by a fiber mixed composition, allows to
partially bypass this issue. Indeed, proteome analysis of these
two muscles in the rat provided two sets of proteins
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quantitative assessment of the different isoform distributions
of some contractile proteins in the two investigatedmuscles, a
greatly different abundance of molecules controlling glycoly-
sis was found. The latter were 4–15 folds more elevated in the
gastrocnemius than in a soleus which, in turn, was charac-
terized by substantially higher levels of carbonic anhydrase 3
and myoglobin. The same was true for the level of several
other proteins such as PDZ-LiM domain protein and glyox-
ylase (more abundant in gastrocnemius) and annexin A6,
regulating Ca2+ release from intracellular compartment, and
HSP20 that were more abundant in soleus. Thus, the muscle
proteome of animal models may provide important hints to
muscle plasticity comprehension. In particular, it helps to
clarify why some muscles are more influenced than others by
changing physiological and or experimental conditions such
as aging, hypoxia, microgravity, lack of exercise, or by
secondary effects induced by the primary defect, as in some
neuromuscular disorders.
4.3. Metabolic response to cold and overfeeding
In addition to being responsible for force generation and
locomotion, muscle is a large mass comprising ~40% of the
human body and a tissue characterized by a wide metabolic
spectrum. Upon mild cold exposure, sympathomimetic drug-
induced thermogenesis [54,55] leads to profound changes in
muscle mass, composition and metabolism by way of muscle
mitochondrial uncoupling and the consequent increase in
energy expenditure [56]. The effects of thermogenesis were
investigated in 9 healthy lean subjects byWijers et al. [57] with
the aim to identify the molecular mechanisms involved and
the individual variability of various metabolic adaptations.
Inter-individual differences of the latter might explain
changes of weight due to small differences in energy
expenditure which can lead to long term weight gain or loss
[58]. The identification of metabolic proteins involved in the
control of the electron transport chain upon overfeeding, as a
control condition, vs overfeeding combined with mild cold
exposure, provided new tools to monitor weight gain. In the
above study, the metabolic responses to cold and overfeeding
of humans (n=9) were determined in a respiration chamber in
baseline conditions during three days of cold exposure and
compared with three days of overfeeding. After each experi-
ment a biopsy was taken from the vastus lateralis muscle and
extracted proteins were analyzed by 2D electrophoresis and
MALDI-ToF MS. Three samples reflecting 3 different condi-
tions (i.e. control, cold exposure and overfeeding), from the
same subject, were run in a 2D gel and fluorescently stained.
Among the 95 differentially expressed proteins, 52 were
identified. The analysis of 46 of them showed a positive
correlation (by the non parametric Wilcoxon test) between
changes in spot density and changes in energy expenditure by
the subjects. The majority of protein changes upon cold
exposure or overfeeding affected enzymes of the glycolytic
pathway. Unfortunately, validation of differential analysis by
2D immunoblots, was not possible due to lack of material, and
1D immunoblots of key glycolytic enzymes did not confirm the
differential proteomic results. Following overfeeding and cold
exposure, the abundance of these proteins increased slightly,but the found small differences were related to inter-
individual variability to thermogenesis adaptation. Moreover,
increased abundance in ATP synthase subunits suggested an
increased ATP production. The authors concluded that the
expectation of a correlation between detected protein changes
and both cold- and overfeeding-induced adaptive thermogen-
esis was not supported by the experimental results. It has
been pointed out that the found interindividual differences in
adaptive thermogenesis might originate from differences in
enzyme activity rather than from changes in protein concen-
tration, suggesting that a different approach, possibly directed
to the assessment of membrane proteins, could be more
reliable to detect proteins responsible for the mitochondrial
uncoupling. Calcium cycling and protein turnover, i.e. mech-
anisms possibly responsible for downstream ATP-consump-
tion should be taken into consideration as well as the energy
status of other tissues such as brown fat and liver. These
conclusions also address the general issue of the limited
number of proteins that can be visualized in a 2D gel and of the
possible discrepancy between protein abundance and protein
activity as well as of the difficulty in choosing the most
appropriate methodological approach to investigate a com-
plex problem such as the one proposed by the authors for
which the use of an internal standard would have been
mandatory.
4.4. Exercise and exercise training
Proteomic studies on adaptive changes of humanmuscles as a
consequence of acute and chronic exercise are missing with
the exception of a recent work by Holloway et al. on interval-
exercise training [59]. Therefore, even though not strictly
related to the aim of this review, at the bottom of this
paragraph, we shall summarize the most significant muscle
proteomic results on exercise and training obtained in some
animal models, particularly the rat. The investigation on
interval-exercise training indicated above was carried out on 5
recreationally active men who underwent a 6 week interval
training protocol on a treadmill [59]. Thirty minute training
sessions were repeated three times a week. Each session
comprised six 1-min runs at 90–100% of maximum oxygen
uptake (VO2max), interspersed by 4 min exercise bouts at 50%
of VO2max. Proteomic analyses were carried out on bioptic
samples from the vastus lateralis muscle taken before the
first, and 72 h after the last training session by 2DE and 1D
SDS, followed by iTRAQ labeling and LC MS/MS. Interestingly,
2DE resolved 256 spots whereof only 20 were significantly
changed. Proteins that were more abundant after interval-
training included metabolic enzymes, myofibrillar, Hsp's and
transport proteins. To implement proteomic data provided by
2DE, the authors introduced 1D SDS combined with iTRAQ
labeling to facilitate quantitative expression analysis of
baseline and post-exercise samples. Interval training signifi-
cantly increased the expression of α- and β-chain subunits of
ATP synthase that correlated positively with the changes of
the encoded Ca2+-calmodulin-dependent kinase II activity. By
1D SDS–LC MS/MS platform, an increment of succinate
dehydrogenase flavoprotein and of the α-subunit of the
mitochondrial trifunctional protein was found, which is
consistent with previous findings by immunoblots after sprint
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protein catalyzes the last steps in β-oxidation of fatty acids.
The α-subunit is associated with 3-hydroxyacyl-CoA dehy-
drogenase and enoyl-CoA hydratase activities and an in-
creased expression of this enzyme suggests a greater capacity
to oxidize fatty acids. The importance of combining two
separation technologies was that the information extracted by
iTRAQ alone does not take into account isoform distribution,
whereas 2DE provides a precise quantitation of the latter.
These findings show that a combination of the two adopted
technologies is required to unravel certain aspects of muscle
complexity, particularly in comparative studies. Among
contractile proteins, troponin T was extensively described in
this paper and specific phosphorylated isoformswere found to
be differentially changed after interval training.
Most of the proteomic investigations on animals were
carried out in rats. The adopted exercise models were
voluntary wheel running, swimming as well as intensity-
controlled treadmill running [61]. Skeletal muscle responses
were investigated at rest, after acute exercise or prolonged
training. Takahashi et al. [62] carried out 2DE on pooled
muscles from rats killed after 150 min of swimming, reporting
reduction of a putative transcriptional factor later identified as
zinc finger protein 3. Guelfi et al. investigated the rat
gastrocnemius 30 min after a 3 min swimming load [63].
Changes of troponin T, creatine kinase, adenylate kinase and
Hsp 20 were detected. Gandra et al. report significant changes
in glycolytic enzymes, Hsp70 and carnitine palmitoyl trans-
ferase, in the recovery phase (3 and 24 h) after a treadmill
effort to exhaustion [64]. With reference to chronic exercise,
Burniston found significant changes in the expression of 15 gel
spots, corresponding to 11 individual genes, 6 of which are
characterized by different alternative splicing gene products
[61]. Endurance training altered the expression of a single
protein isoform of transferrin, albumin, lactate dehydroge-
nase A (LDH A), phosphoglucomutase 1 (PGM1), triosepho-
sphate isomerase and mitochondrial aconitase (ACON 2). The
significance of changes in isoform distribution of these
enzymes has not yet been clarified. As far as PGM1 is
concerned, according to the authors, the general decrease in
abundance of this protein could correspond to a significant
decrease in its enzyme activity, whence the lesser ability to
utilize glycogen with corresponding saving of the muscle
stores of the latter and a greater use of fatty acids. Therefore,
validation of the postulated mechanism will be useful.
Yamaguchi et al. [65] have recently investigated by 2D-DIGE
the changes induced by 5 days of high intensity swimming
interval-training on the proteome of the rat epitrochlearis
muscle. 13 proteins,mainlymitochondrial enzymes, exhibited
changed expression compared to sedentary controls. An
alternative experimental model for obtaining a comprehen-
sive proteomic profiling of muscle transformation during
exercise, is that of chronic low-frequency stimulation. Dono-
ghue et al. analyzed by 2D-DIGE the protein differential
expression response of the rabbit tibialis anterior (a fast
twitch muscle) of 14 and 60 day conditioned animals vs
unstimulated controls [66].This comprised 41 protein species
belonging to various known functional classes whose conver-
sion, confirmed by immunoblotting, was toward slower twitch
characteristics. As far as exercise is concerned, a transfer ofproteomic differential data from animal models to human
muscles is, at present, unwarranted.
4.5. Aging
Aging is characterized by a loss of muscle mass (sarcopenia),
which in moderately-active, 75 year-old male subjects, may
account for ~25% of the lower limb muscle mass with
concomitant reduction inmaximal cross sectional anatomical
and physiological areas, fascicle length, fiber pennation angle,
maximum voluntary force and relaxation rate [67–69]. Func-
tional changes at the fiber level include a loss of specific force
both in vivo and in vitro [12,70,71]. Reported changes in fiber
type distribution are contradictory, having featured either a
shift toward a slowermuscle phenotype following preferential
denervation of fast motor units [72], no change at all [73,74] or
even a shift toward a faster phenotype [12,75]. Age associated
molecular changes include reduction in myosin heavy chain
(MHC) [12,76], though the distribution of myosin light chains
(MLC) remains unchanged, reduced protein synthesis [77],
accumulation of lipofuscin [78], impairment of excitation–
contraction coupling [79] and decline in respiratory chain
function [80]. Given the complex nature of the aging process,
considerable inter-individual and inter-group variabilities in
age-related sarcopenia are not surprising. Since the amount of
tissue obtainable at biopsy is necessarily limited, a joint
assessment of all relevant parameters may not be possible.
Age-dependent changes in contractile and metabolic proteins
of the vastus lateralis muscle in two groups of physically
active elderly and young subjects were assessed by 2D-DIGE
with the aim of reducing the confounding effects of inter
subject and group variations of both sarcomeric andmetabolic
proteins [43]. Vastus lateralismuscle samples of 6 subjects aged
70–76 years were compared to those of 6 individuals aged 20–
25 years. What appears of relevance is the drastic change, in
the elderly, inmetabolic proteins with a decrement of creatine
kinase and of most enzymes involved in aerobic metabolism
paralleled by an increment of those regulating anaerobic
glycolysis. Myoglobin, sarcosin and peroxiredoxin 2 were also
less abundant in the elderly, whereas glutamic oxalacetic
transaminase 1 (GOT-1) was increased. Major differences were
observed at the contractile level with decrements of MHC
fragments, of the tropomyosin R chain and of troponin T
levels. Differences were also observed in myosin light chain
isoform distribution with changing abundance of slow and
fast isoforms. Concentrations of fast isoforms of myosin
regulatory light chains (MLC) and, in particular, of the
regulatory phosphorylatable isoforms known to modulate
the rate of force development and of twitch maximal force at
different initial tension levels [81–83], both of which are
relevant to muscle function, were decreased. In vitro phos-
phorylation of MLC is known to increase calcium sensitivity
thereby controlling the rate of force development and
maximal force [84]. The drop of phosphorylatable isoforms
and the decrement of phosphorylation of the acidic MLC f
isoform found in elderly subjects, could impair performance.
As is well known, aging induces a progressive reduction of the
knee extensor muscle mass and maximal force, as well as of
the maximum aerobic power (VO2max) of the whole body.
Thus proteomics allows to correlate the locomotor functional
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specific metabolic, contractile and stress response proteins
granting new insight into the origin of both ultrastructural and
functional changes induced by aging. Interestingly, a study
[85] on the effects of aging performed on humanmitochondria
by ICAT labeling and LC MS/MS showed a decrement of most
oxidative enzymes. Unfortunately, the authors did not exam-
ine simultaneously the protein profile of the whole muscle,
leaving unanswered two important functional aspects, i.e., the
levels of enzyme activity and the efficiency of the mitochon-
drial function.
Animal models may be a source of useful information on
muscle proteome dysregulation induced by aging and several
animal studies were extensively discussed. Aging was inves-
tigated comparatively in different rat strains standardized for
age on the basis of their life expectancy. Proteomic analysis
identified changes correlated to morphological abnormalities
in metabolic, contractile and cytoskeletal proteins, a dysregu-
lation of iron homeostasis, a change in Ca2+ balance and in the
level of stress response proteins [86]. A recent interesting
finding in the rat was a parallel dysregulation, with aging, of
the protein pattern of gastrocnemius and of the sciatic nerve
controlling it [87]. By analyzing proteomic data from the two
tissues, besides dysregulation of the membrane adhesion
proteins and of proteins regulating the neuronal caliber, 16
protein isoforms showed a parallel up or down changing trend
in nerve and muscle. These findings may imply the existence
of a common process acting as a signal event of degeneration
in the two tissues. Only β-enolase and tropomyosin 1A were
differentially expressed in the two tissues appearing to be
specific markers of aging [87].
4.6. Effects of immobilization
Prolonged bed rest is known to induce substantial atrophy of
lower limb muscles characterized by reduced cross sectional
area (CSA) and fascicle length.
The effect of bed rest without and with vibrational exercise
countermeasures (RVE) on the proteome was assessed in two
groups of subjects by 2D-DIGE and MALDI-ToF MS/MS or ESI
MS/MS in two functionally and structurally different muscles:
the vastus lateralis (VL) and the soleus (SOL) [88]. SOL is
characterized by being a predominantly slow (~35:65%) twitch
muscle whereas VL is a mixed type II/I (~50:50%)muscle. After
55 days of forced bed rest, both VL and SOL underwent in
control subjects (CTRL), decrements of ~15% in cross sectional
area (CSA) and of ~22% in maximal torque that were
prevented by RVE. MHC distribution showed in CTRL, both in
VL and SOL, increased type I and decreased type IIA fibers
whereas the opposite was foundwith RVE. A substantial down
regulation of proteins involved in aerobic metabolism char-
acterized both SOL and VL in CTRL, whereas proteins involved
in anaerobic glycolysis were up-regulated. RVE reversed the
pattern more in VL than in SOL. In the thin filament, changes
of contractile proteins involve cardiac and skeletal actins,
troponin subunits, LIM domain and myozenin proteins. This
functional impairment could profoundly influence the calci-
um-activated signaling process associated with the Z disk
function. Also the organization of the thin filament appears to
be influenced by bed rest. In fact, the end capping proteingelsolin increased during bed rest whereas troponin T was
found to be less abundant, suggesting that the single
regulatory units of the thin filament were also perturbed
[89]. RVE countermeasures appear to counteract the above
described alterations by increasing troponin T and gelsolin.
The disruption of the sarcomeric organization could also be
the consequence of a loss of titin as observed in animal
models [90]. The latter proteinwas not detected by the present
analysis. Mechanical stress sensors are not limited to the
Z-disk region. They are also embedded in muscle-specific
membrane systems such as the costamere, intercalated disks,
and caveolae-like microdomains (vinculin, desmin, and WD
repeat). Indeed, some of the contractile proteins involved in
mechanical stress [91], were dysregulated. Proteins from the
Z-disk region and from costameres were differently dysregu-
lated during bed rest without and with countermeasures,
particularly in VL. RVE appears to counteract these events only
partially, and it is difficult to assess if the protocol adopted in
this study aimed at counteracting muscle loss, is the most
appropriate to restore muscle function. A bioinformatic
analysis by IPA software positioned dysregulated molecules
in a broader AHR complex negative acute phase response
pathway. The stress induces transcriptional activation of
genes encoding xenobiotic metabolizing enzymes, phase II
metabolizing enzymes (Glutatione-S-Transferase, NADPH-
quinone oxidoreductase, UDP-glucuronosyl-S-transferase)
and other growth factors and proteins involved in cell cycle
progression and apoptosis. These events could bemediated by
calcium-activated signaling, in particular via calcineurin,
whose modulation induces nuclear transcription. With regard
to the negative acute response phase mediated by NF-kB
signaling, the activation of this pathway supports the possible
positive role of a mechanical stress response. The comparison
of the metabolic dysregulation pattern induced in the two
investigated anatomically and functionally different muscles
by bed rest without and with vibration countermeasures
provides unique information on the muscle protein signature
during prolonged inactivity and, moreover, on the potential
benefits of adequate exercise countermeasures to be adopted
during and after long-lasting space flights as well as for
rehabilitation after trauma of the locomotor apparatus.
The effects of immobilization was also investigated in the
rat by differential proteomic analysis after varying duration of
hindlimb suspension [92–95]. As observed in humans after
prolongedbed rest, remodeling of a posturalmuscle (the soleus)
phenotype, results in a fiber type shift from slow oxidative to
fast glycolytic which is paralleled by an increase in muscle
fatiguability. 2D-DIGE, mass spectrometry and biochemical
assays were applied to assess qualitative and quantitative
differences in the proteome of the rat soleus muscle subjected
to disuse. The results indicate amodulation of troponin I and of
the tropomyosin complex regulating fiber type transition from
slow to fast, and suggesting a new role of both the above
proteins in the regulation of fiber type transition during
unloading. In addition, changes in calcium sensitivity and
cooperativity seem to precisely regulate MHC transition from
slow to fast phenotypes. Associated with, or induced by
unloading, metabolic changes occurring in the atrophied
muscle were also detected in the proteome, such as an
increment of glycolytic enzymes and a decreased capacity of
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acted by acetyl-L-carnitine treatment which restores the
mitochondrial mass and decreases glycolytic enzyme expres-
sion, suggesting a normalization of themetabolic shift observed
after 14 days unloading. This normalization of the metabolic
machinery is accompanied bymaintenance of body weight and
seems to prevent a switch of fiber types. The proteomic data
closely agree with what was expected from the loss of function
and change in muscle mass and in the body index in this
animal model and are also in agreement with the changes
observed in the human soleus after 55 days of bed rest [88]
contributing to open new avenues for the comprehension of the
signaling events responsible for the functional changes ob-
served in unloadedmuscles. From the above studies, even if the
applied protocols of unloading are different (bed rest in humans
vs hindlimb suspension in rats), there are hints that results
from animal models may parallel human data, particularly
when the muscles are characterized by the same fiber type
composition and exhibit similar phenotype changes under the
same paraphysiological conditions. The finding that acetyl-L-
carnitine supplementation restored the metabolic control of
unloaded muscle, might be expected to counteract also the
functional impairment of human soleus induced by bed rest.
The latter could hopefully be an example of the possibility of
transferring to humans results from animal models.
4.7. Effects of eccentric upper extremity exercise on plasma
proteome
Blood concentrations of creatine kinase (CK), myoglobin,
troponin isoforms and lactate dehydrogenase (LDH) are
extensively monitored in clinical chemistry as biomarkers of
muscle injury [96]. Nevertheless, they remain poorly informa-
tive of the muscle status and can't discriminate between a
tissue injury or a recent exercise performance. Therefore, the
identification of biomarkers able to detect muscle damage in
biological fluids, is increasingly needed and newmethods able
to identify them avoiding the invasive procedure of muscle
biopsy, would be very suitable, particularly, for the study of
muscle disease. Sietsema et al. [97] adopted, recently, the
plasma profile of nine, age- and gender-unmatched volun-
teers, to identify biomarkers of muscle damage induced by
eccentric exercise. Samples also included diabetic patients as
an example of chronic disease. Subjects were monitored at 5
different times, before and after the end of exercise. Plasma
underwent glycopeptide enrichment, followed by LC MS/MS
[98–100]. Potential protein markers with at least 2 distinct
peptide components increasing during exercise as a function
of work load and duration, were selected. The selection was
based on a pair-wise correlation of peptide abundance for all
subjects at each time point, and the peptides meeting the
requirements were chosen as putative biomarkers. Four
proteins were found to meet the criterion: alpha 1 antic-
hymotrypsin (ACT), plasma protease C-1 inhibitor, hemoglo-
bin α and β chains, thereby indicating that the detected
changes were not spurious variations but were induced by
exercise. Across the subjects the fold-change of the four
proteins did not correlate with that of the CK levels. A
correlation of 3 of them with CK was observed, whereas ACT
and C1 changes, known markers of inflammation, precededthe increment of CK. No differences were detected between
normal subjects and diabetic patients. In addition, the limited
number of subjects precluded the possibility of identifying
specific biomarkers of muscle damage related to aging. The
results of this study in healthy subjects indicate that plasma
proteomics may have a potential for identifying biomarkers of
muscle damage, even though the biological significance of the
described changes is still not quite clear. It should be pointed
out that a small number of investigated plasma samples and
their heterogeneity due to biological variability may hamper
tentative correlations of significantmarkers. By increasing the
number of investigated subjects, the number of significant
changes may possibly decrease, being likely more than
compensated by an increased robustness of the results.
Animal models could provide further hints for the detection
of new biomarkers of muscle damage in sera, particularly
when based on an extensive proteome analysis of muscles
differently affected by the disease as is the case for the mdx
animal model [101,102].5. Differential proteomics in the study of
muscle pathophysiology and pathology
Disorders affecting muscle function mainly comprise a group
of rare diseases with heterogeneous phenotypes, the so called
neuromuscular hereditary disorders (NMDs), studied inten-
sively, both in terms of genetic definition and pathophysiol-
ogy. Other diseases affecting muscle function are the
consequence of disorders in which muscle is not the primary
target, such as inflammation and diabetes. Regarding the
treatment of the above described pathology, most of the
ongoing trials are designed to correct or counteract the decline
of specific altered functions. Tomonitor the benefits of a given
intervention at the individual level, classical clinical markers
of muscle damage such as immunohistochemical alterations,
enzyme dysregulation, changes of contractile and transport
proteins, are not always sensitive enough for detecting slight
changes in disease progression. Differential proteomics, by
monitoring more precisely the level of specific markers, could
improve diagnosis and the follow-up of these pathologies. The
development of genetically engineered animal models can
significantly contribute to the definition of some pathophys-
iological mechanisms of NMDs, particularly of the role of
secondary events leading to muscle weakness and early
death. With the aid of such models, repeated analyses at
different stages of evolution of the primary disease or in the
progressive involvement of different muscles are now becom-
ing feasible. This avoids some of the bias deriving from
interindividual variability and from restricted sample avail-
ability. Dedicated animal models, thanks to their well defined
genetic background where the primary defect is imposed, are
easily age- and gender-matched, and their nutritional and
environmental parameters can be strictly controlled, thereby
potentially providing reliable biomarkers of secondary events
that could be hopefully extended to the study of NMDs. In
addition, parallel investigations in patients and in suitable
engineered animal models, could be useful to make it possible
to translate some findings from animals to humans. Indeed,
protein profiles of muscle diversity in patients and animal
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immobilization, can facilitate phenotype comparison and
correlation of specific datasets, allowing to identify significant
molecules for monitoring. Development of new animal
models shall contribute to improve the knowledge of rare
human muscle diseases as well as of the features of their
progression, thereby avoiding recurring invasive analyses in
patients that are necessarily limited on ethical and technical
grounds. Unfortunately, despite the number of investigations
on mdx animal models [102] which largely contributed to the
comprehension of pathophysiological mechanisms associat-
ed with lack of dystrophin, as far as we know, no investiga-
tions on the human muscle proteome were conducted on the
Duchennemuscular dystrophy. What follows is a summary of
the proteomic studies carried out in NMD patients and in type
2 diabetes over the last years.
5.1. Dysferlinopathies
To clarify the physiopathology of an important NMD disease
affecting sarcolemmal membrane integrity, a differential
proteome analysis of the quadricepsmuscle of patients affected
by a dysferlinopathy in comparison with healthy control
individuals was conducted [103]. Biopsies were obtained from
9 patients and 6 healthy control subjects. To improve the
detectability of isoform distribution of contractile proteins, the
samples were analyzed in a 3–10 NL pH gradient and in a
narrow acidic range, pH 4.5–5.5, and gels were quantitated.
Mutations in the gene for dysferlin (Dystrophy associated fer-1-
like protein) cause muscular dystrophy in humans, such as the
limb-girdle muscular dystrophy type 2B (LGMD2B) and the
distal muscular dystrophy of Miyoshi (MM) [104]. The dysferlin
gene encodes a type II membrane-associated protein belonging
to the ferlin family, which is localized in the sarcolemma and
implicated in calcium dependent phosopholipid binding
[105,106]. Dysferlin interacts with caveolin-3 and seems to be
involved in the mechanism of membrane fusion and repair.
Genetically, the disorder is well characterized. In muscles of
patients affected by LGMD2B or MM, an inflammatory response
associated with fiber degeneration and myopathology is
frequently observed, whose origin, however, is unknown.
Though clinical symptoms of the disease occur in the second
decade, damage to muscle ultrastructure and changes of CK
levels are already evident before their appearance. Muscle
regeneration interferes with inflammatory response and dis-
ease progression. Signs of muscle regeneration were shown
preceding inflammation and complement cascade activation
[107]. A disruption of the muscle repair machinery seems to be
responsible for dysferlin-deficient muscle degeneration, high-
lighting the importance of the cellular mechanisms of mem-
brane integrity in the pathogenesis of the disease [108]. Several
markers related to protein synthesis and folding and heat shock
protein 90 (P08238), were found to be up-regulated in patients,
suggesting that an increased protein synthesis could be related
to muscle regeneration [108]. Metabolic proteins appear to be
dysregulated with proteins involved in respiratory chain
activity being more abundant and glycolytic enzymes such as
α-enolase and phosphoglyceromutase less abundant in
patients. Alterations in contractile proteins suggested a defect
in the actin bundle formation with a decrement of α-actin andan increment of α-actinin known to anchor actin to the
intracellular structures, and of WD-repeat protein 1 involved
in actin filament disassembly [109,110]. These changes may be
due to the impairment of the membrane protein repair system
characteristic of dysferlinopathies. Patients also display an
anomalous behavior of regulatory myosin light chains (MLC)
affecting both slow and fast fibers. The quantitative evaluation
of the corresponding spots in muscle samples from patients
indicates a switching from fast to slow twitch fiber types and a
reduction of the phosphorylatable isoforms in the fast fibers.
The latter change is known to be responsible for a reduction of
the maximal contractile velocity and force by the muscle [82],
hence, the patient's functional impairment. The described
study raises the questions of how to discriminate between
protein changes induced by disuse as opposed to inflammation,
and of the relationships of the latter with dysregulated proteins
typical of the primary defect (Fig. 9). Indeed, only an extensive
comparative study of different diseases affecting a specific
component of the contractile machinery could generate
adequate data, making it feasible to associate given sets of
biomarkers with specific diseases.
5.2. Facioscapulohumeral muscular dystrophy
As previously stated, NMDs are a genetically well defined set of
disorders. A disease representing an exception to this noso-
graphic classification is the autosomal dominant facioscapulo
humeral dystrophy (FSHD). In fact, the defect is not only linked
with a mutation in a specific, recently identified [111] gene
(DUX4), but is also correlated to the arrangement of the
telomeric region D4Z4. FSHD is caused by the deletion of an
integral number of 3.3-kb KpnI repeats inside the telomeric
region D4Z4 at the 4q35 locus. Despite the identification of the
molecular mutation, the role of the D4Z4 arrangement is still
under debate. In its classical symptomatology, FSHD is
characterized by early involvement of facial and scapular
muscles. However, besides being characterized by variable
penetrance, this condition presents a wide and heterogeneous
spectrum of clinical features. Immunohistochemistry and a
muscle specific cDNAmicroarray platformwere combinedwith
proteomic data to analyze muscle samples of patients charac-
terized by a variable number of KpnI repeats [31]. Unsupervised
cluster analysis divided patients into three classes according to
their KpnI repeat number, suggesting a role for the D4Z4
arrangement in transcriptional and proteomic pattern changes.
Among the scapular muscles, the deltoideus, is the least
affected, exhibiting minimal to mild myopathic symptoms in
all patients, so that protein and transcript changes could
reasonably be attributed to the primary genetic defect rather
than to the underlying pathology. Alterations in the expression
levels of transcripts and proteins controlled by the muscle-
specific transcription factor MyoD were detected, and the level
of impairment in differentiation from slow to fast muscle fibers
was found to correlate to the size of the contracted D4Z4 region.
The above results suggest that crucial factors in disease
progression could be defects in the MyoD-dependent gene
network and in cell differentiation. Proteomics indicates that
cell cycle regulators are reduced, among the latter, the NEDD8
gene product. This is a ubiquitin-like post-translational mod-
ifier that is covalently linked to the cullin (Cul)-family proteins,
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Fig. 9 – Schematic representation of the dystrophin-associated protein complex. The distrophin complex is an assembly of
proteins that connect inner cytoskeleton with extracellular matrix.known to enhance ubiquitinating activity and to play a central
role in differentiation via degradation of cell cycle regulators
[112] and of Hsp70, involved in cyclin maturation [113]. The
nuclear transcription factor NF-kB, regulated by NEDD8 activity
is also increased andmay induce further loss of MyoDmRNA in
FSHD muscle, thereby interfering with skeletal muscle differ-
entiation. With regard to fiber type composition, transcription-
al, proteomic and histochemical analyses, support the presence
of an increased number of slow type I fibers in severely affected
muscles of FSHD patients. The changed proportion of these
fibersmay be the result of an adaptation to the disease, or of an
adult muscle's failure to properly regenerate. This fiber type
shift is compatible with comparative differential proteomic
data of human muscles in aging, except that MLC phosphor-
ylated isoforms are unchanged in FSHD patients contrary to
healthy elderly subjects despite the similar distribution of MHC
suggesting that fiber type switching is under different upstream
regulators. In addition, most proteins involved in oxidative
stress responses are decreased according to the number of KpnI
repeat units, which reflects a progressive inability of the
antioxidant defenses to maintain cellular homeostasis. The
changed expression of theCa2+-dependent transcription factors
NFATs and MEF2C and of signaling molecules such as
calmodulin and troponin C, probably amplifies the degenera-
tive process. From these results it may be concluded that D4Z4
contraction may affect the expression of transcription factors
involved in myogenesis with implications for the function of
the regeneration pathway of satellite cells in adult tissue.
Parallel proteomic studies on FSHD animal models might be
suitable for validating some of the hypotheses put forward by
investigations on patients.5.3. Inclusion body myositis (IBM)
Three studies from different groups adopted the proteomic
approach to investigate inclusion body myositis, an inflamma-
tory disease of skeletal muscle of unknown origin. The first two
studies didn't reach the goal due to a limitednumber of patients
and an insufficient amount of muscle samples [114–116]. To
better understand the nature of the tissue injury in this disease,
a further study including immunohistochemistry, gene expres-
sion profile and proteomic analysis was performed on 17
patients with inflammatory myopathies and on 3 elderly
healthy control subjects [117]. A loss of fast twitch fibers,
sarcomeric proteins and glycolytic enzymes was found. Protein
profiling was obtained adopting tryptic digestion after protein
extraction and HPLC ESI MS/MS. Approximately 10.000 spectra
were collected per LC/MS run, and row files were converted to
Mascot and searched against the human international protein
index database. All matches were manually curated [118]. Two
distinct peptides were required for protein identification and
spliced isoforms of the same gene were not considered.
Identified peptides were assigned consistently to the smallest
possible list of identified muscle proteins due to their large
number of shared peptides [119]. A gene expression profile was
conducted on 31 samples, which also included different
diseases such as polymyositis (PM) and dermatomyositis (DM)
using the Affymetrix platform representing 18,000 genes.
Samples were characterized by immunohistochemistry, adopt-
ing ATP ase and specific antibodies toward MHC isoforms for
fiber typing and antibodies for glycogen debranching amylo-
1,6-glucosidase and alpha actinin-3 assessment. Proteomic
analysis identified 300 distinct proteins in each biopsy and
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each sample by dividing it into 4 pieces. Intra sample
reproducibility was high. However, large inter-individual vari-
ability was observed. Proteomic results indicate a loss of fast
twitch isoforms of muscle proteins accompanied by a decre-
ment of structural proteins such as actinin 3, troponin type 3,
myozenin, myomesin 2 and MLC 1. The loss of fast twitch
isoforms was present in all inflammatory myopathic patients,
and the same loss of fast fibers was observed, even though to a
lesser extent, in PM and in DM. Comparisons with the results
obtained in other inflammatory diseases were made by
immunohistochemistry. Regeneration was also present with a
great increment (18 fold) of myosin heavy chain H3 (embryonic
myosin). The latterwas common to PM andDMas confirmed by
immunohistochemistry. Metabolic proteins were dysregulated
with a reduction of 4 glycolytic enzymes, the greatest reduction
being observed for the glycogen debranching amylo-1,6-gluco-
sidase also common to PM and DM. By contrast, α-glucagone
transferase was specific for IBM. Laminin-A/C was decreased,
whereas immunoglobulin heavy chains and α-filamin, a
substrate of calpain-3, were more abundant in these patients.
Laminin decrement may reflect nuclear degeneration whereas
the abundance of immunoglobulin may reflect infiltration of
β-cells into muscle. Several components of the extracellular
matrix were also overexpressed in agreement with the found
fibrosis and the presence of connective tissue. Limitations of
this extensive studywere admitted by the authorswho couldn't
identify either β-amiloid precursors or titin and collagenwhich,
by contrast, were found in abundance in diseased and normal
samples by immunohistochemistry. The authors concluded
that the adopted proteomic platform was less sensitive than
immunohistochemistry. However, it should be pointed out that
proteomics is an unbiased approach and even if it failed to
detect some of the proteins known to be changed in inflam-
matory diseases, it could identify filamin A and the AHNAK, a
nucleoprotein involved in subsarcolemmal cytoarchitecture
and membrane repair. The latter, known to interact with
dysferlin and, together with filamin A, a substrate of calpain-3,
is accumulated through calpain deficiency [120]. The major
concern of the authors was the variability in protein abun-
dances even among samples of patients affected by the same
disease. This finding likely reflects the many confounding
variables, such as age and gender, severity of the disease,
chronicity, and other factors characteristic of each particular
patient, making a differential study extremely complex. The
choice of samples to be compared, e.g. normal vs diseased, or a
different severity of the investigated conditions, or differences
between diseases characterized by similar phenotypes, as well
as the choice of an adequate technological approach and of the
procedures to validate differential results, represent factors
that cannot be disregarded.
5.4. Dermatomyositis with muscle perifascicular atrophy
Dermatomyositis (DM) is an autoimmune disease primarily
involving muscle and skin [121,122]. Recent microarray
studies have pointed toward a mechanism of tissue injury
associated with the overexpression of type 1 interferon-
inducible gene [123,124]. Interferon-stimulated gene 15
(ISG15) conjugated proteins in DM muscle with muscleperifascicular atrophy, were investigated by Salajeheh et al.
[123]. ISG15 is a poorly understood ubiquitin-likemodifier. The
enzymatic pathway for ISG15 conjugation to a target protein
involves three conjugating and one deconjugating enzymes
[125–128]. The conjugation of ISG15 to proteins in human
tissue samples has been reported in colon cancer but the
identity of such proteins remains unknown [129]. The above
study included 113 patients with a variety of muscle diseases,
76 were affected by immune-mediated inflammatory myopa-
thies, 26 by non-inflammatory myopathies and 11 had no
evidence of neuromuscular disorders. Microarrays, immuno-
histochmistry and proteomics were utilized to analyze the
samples. Proteomics was performed using LC MS/MS on
muscle biopsy extracts and on muscle cells after laser capture
dissection. Microarrays indicate that transcripts encoding for
ISG-15 conjugation pathway proteins were markedly up-
regulated in DM with perifascicular atrophy. Free ISG- and
ISG-conjugated proteins were only found on immunoblots
after SDS from DM patients. Cellular cultures of human
skeletal muscle exposed to type 1 interferon produced similar
transcripts, ISG15 proteins and conjugates. In addition, laser
capture microdissection followed by proteomic analysis
showed a number of dysregulated proteins such as nebulin,
troponin, myomesin, Zasp, MHC slow and fast isoforms,
myosin binding protein C, voltage-dependent anion channel,
myotilin, CK, fatty acid binding protein, glyceraldehyde 3-
phosphate dehydrogenase, carbonic anydrase, peroxiredoxin,
and Hsp70, whose changes were common to other diseases.
Peculiar of DM patients with perifascicular atrophic myofibers
was a deficiency of titin. The latter result appears to be the
most peculiar feature of the disease. Unfortunately, the study
has failed to detect ISG15-conjugated proteins both in cell
cultures and in muscle tissue.
As it appears from the above paragraphs, proteomics can
profile secondary events related to primary NMDs, thereby
providing insight into the muscle ability to cope with
dysfunctional proteins or the effects of inflammation. For
instance, muscle regeneration characterized by overexpres-
sion of embryonic MHC and associated with metabolic
adaptations, as assessed by proteomic analysis, represents
one of the primary events whose absence is accompanied by
muscle loss. Inflammation is associated to a typical dysregu-
lation of the proteome, whose main feature is the decrement
of antioxidant enzymes preventing muscle tissue to buffer
ROS production and to control Ca2+ unbalance, thereby
inducing fiber switching from fast to slow type. Selected sub-
proteome analysis, (e.g. of organelles andmembranes, of post-
translational modifications, of silencing of specific genes, of
responses to different pharmacological treatments), could
shed light on the physiopathological mechanisms specific of
or associated to a given disease. The extension of proteomic
studies to new, well characterized, pertinent animal models is
recommended for further investigations in human pathology.
5.5. Insulin resistance
The first investigation adopting the 2DE approach aimed to
identify biomarkers was applied to the differential analysis of
skeletal muscles of patients affected by insulin resistance [45].
The latter condition is typical of type 2 diabetesmellitus (T2DM)
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oxidative glucose metabolism in muscle accompanied by an
impairment in glucose oxidation and by suppression of lipid
oxidation after insulin stimulation [130–132]. These features
suggest an altered capacity to switch between carbohydrate
and fat as an oxidative energy source due to impaired
mitochondrial metabolism [133–137] and altered signaling of
known sensors of energy stress imbalance, such as AMP-
activated protein kinase (AMPK) [138] by way of the transcrip-
tional co-activator of peroxisome proliferator activated recep-
tor, PGC-1α. The latter is known to promote mitochondrial
biogenesis and to increase the glucose transporter type 4
(GLUT4) protein content in muscle [139–141]. The finding of a
general decrement of oxidative capacity in the whole muscle
mass of T2DM patients rules out the possibility that the above
change is attributable to an increased proportion of type 2
muscle fibers [142]. In order to identify markers of T2DM in the
fasting state, a differential proteomic study utilizing 2DE and
mass spectrometry was performed on the vastus lateralis
muscle of 10 obese patients with T2DM, where 5 were treated
with diet and 5 with low doses of either sulfonylurea or
metformin, and 10 healthy age- and gender-matched control
subjects. 15 proteins were found differentially expressed in the
two groups and 11 of them were identified by mass spectrom-
etry, i.e. 3metabolic enzymes: ATP Synthase-subunit β (ATP Sin
β) and brain creatine kinase (CK-B) whichwere down regulated,
and phosphoglucomutase (PGM-1) which was increased in
patients; 2 heat shock proteins, Hsp90β and GRP78, which were
up-regulated in patients; different isoforms of structural
proteins, i.e. 4 isoforms of α-1 chain of type VI collagen (α1
(VI)) and one isoform of MLC2 which were also up-regulated,
whereas one isoform of MLC2 was down-regulated. A number
of correlations were attempted both in T2DM patients and
control subjects, e.g., among: a) protein markers such as ATP
Sin β, CK-B and α1(VI) and fasting plasma glucose levels; b) ATP
Sin β and CK-B and FFA levels; and c) PGM-1 and insulin levels,
body mass index, etc. The results appear rather weak and are
characterized by large variability, possibly due to the relatively
small number of investigated subjects. Interestingly, a study of
phosphorylated isoforms of protein markers in T2DM patients
was also conducted by 2DE in [32P]-phospholabeled human
myoblasts. It revealed that a number of differentially expressed
proteins were phosphorylated and that post-translationally
modified isoforms followed the up- or down-regulation of the
corresponding protein. Whether the above described and other
significant changes are secondary to hyperglycemia, hyperin-
sulinemia, altered muscle fiber type composition or whether
they are indicative of a primary metabolic defect in T2DM
patients remain matters for investigation.
Hwang et al. performed an extensive proteome differential
analysis in 3 groups of 8 subjects each, comprising healthy lean
and obese subjects and T2DM patients, adopting 1D electro-
phoresis followed by HPLC ESI MS/MS [143]. Muscle proteins
were quantitated using normalized spectral abundance factor
methods (NSAFs). When the results for all 24 subjects were
combined, 1218 proteins were identified. Proteins that were
found in at least half of all participants totaled 400, of which 92
were increased or decreased by a factor of 2 in at least one of the
3 possible two group-comparisons (obese vs lean, diabetic vs
lean, and diabetic vs obese). Of the 92 altered proteins, 15 weresignificantly different among the investigated groups by one
way ANOVA (p<0.05). Proteins with decreased abundance in
T2DM patients were different from those identified in a
previous study [45]. The authors pointed out the limits of
their work (subjects were not age-matched with controls, weak
statistical analysis) thatwas considered only a starting point for
additional more focused investigations designed to test the
hypotheses put forward by their previous findings. Comparing
results of the two reported proteomic studies onT2DMpatients,
the first conclusion that can be drawn, is the higher sensitivity
of 1D HPLC ESI MS/MS for protein identification compared with
2DE but the lower robustness of the differential analysis.
Animal models were also adopted to evaluate protein
expression changes associated with type 1 diabetes. Johnson
et al. investigated by 2DE the protein expression of liver, heart
and skeletal muscle of diabetes-prone rats [144]. The study
provided interesting observations e.g., the limited involve-
ment of skeletal muscle in this disease. In fact, only 9 proteins
were found to be differentially expressed in the muscle
compared to 341 proteins changed in the liver. These results
are consistent with the known large alterations in liver
metabolism associated with a lack of insulin, mimicking
systemic starvation. In a recent paper, Ohlendieck et al. [145]
adopted the GK rat model of type 2 diabetes [146], a
spontaneously non-obese diabetic animal exhibiting chronic
impaired insulin signaling, to investigate changes in the
proteome of the gastrocnemius. The latter muscle was
characterized by decreased recruitment of the glucose trans-
porter GLUT 4, abnormal mitochondrial functioning and
reduced population of slow-twitch fibers. The proteome of
this animal exhibited a limited number of protein changes and
the diabetes-related changes of metabolic enzymes were
particularly moderate. Among the 7 decreased proteins,
carbonic anhydrase 3 and hydroxy-isobutyrate dehydroge-
nase were the most relevant. Mitochondrial markers, apart
from dihydrolipoamide succinyl transferase, were increased.
Also glycolytic enzymes were at variance. Whereas it appears
difficult to figure out how insulin resistance triggers these
altered enzyme expression patterns, the found changes in
enzyme abundance could certainly modify the glycolytic flux
in diabetic muscle. In this model, the most altered enzyme
was the monoglyceride lipase. In analogy with human data,
adenylate kinase 1 was increased as were the mechanisms
aimed to counteract dysregulation of thin filaments with
increments of α-actin and of the capping protein of the actin
filament. Increased levels of stress-response proteins and
anti-oxidant markers, such as the small heat shock protein
Hsp27/B1, of 3-mercaptopyruvate sulfurtransferase and Cu/Zn
superoxide dismutase, were observed, hence the need to
counteract diabetes-induced cellular damage. This was the
first study on this rat model. Further efforts should bemade to
better characterize the above described pathophysiological
mechanisms, even though the adopted mild phenotype could
be a limitation for a direct correlation with human data. In a
following study on rat gastrocnemius muscle by 2DE [147], the
effect of the treatment with fenofibrate, a drug used to treat
high cholesterol and triglyceride levels, was investigated. The
latter acts as an agonist of PPAR-α, a transcriptional factor
regulating gene expression playing an important role in
activating many proteins catalyzing lipid metabolism, and
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Many proteins were found to be influenced by the treatment,
particularly the c11orf 59 protein (whose function is unknown)
and the signal protein phosphatidylethanolamine binding
protein and IkB-interacting protein. The authors hypothesized
that the identified proteins were involved in controlling lipid
or carbohydratemetabolism in diabetes via PPAR-α activation.
This hypothesis appears to be preliminary and requires
further validations, particularly in patients.6. Conclusions
Notwithstanding its obvious limits, this review featuresmost of
thework that has been carried out inhumanmuscle proteomics
from the onset of research in this area. Along with genomics,
proteomic technologies (adopting all available methods) represent
so far the most powerful means for a systematic characteriza-
tion (separation and identification) ofmuscle proteins. In fact, it
has made it possible to describe the status of both contractile
andmetabolic proteins and of their changes for a wide range of
physiological, paraphysiological and pathological conditions.
Proteomics highlights the various aspects of plasticity of
muscles which are ultrastructurally and functionally greatly
diverse. Comparative or differential proteomics has allowed the
unraveling of some of the most specific metabolic adjustments
occurring inmuscles, asa functionofexercisemode (e.g. aerobic
vs anaerobic), of changes of environmental conditions (hypoxia,
simulated hypogravity, thermal adaptation, etc.), feeding and
overfeeding, gender, ethnic characteristics and of aging.
Throughout this review, which deals mainly with human
proteomics, data from animal models have been occasionally
reportedwhen human data were totallymissing or results from
animal studies, carried out on similar experimental protocols,
were available for comparison. From these studies new
hypotheses couldbeput forwardand trends, towardbiomarkers
discovery and modulation, identified. After having set the
baselines in healthy volunteers, a pre-requisite for the study
of pathology, proteomic technologies were also applied to
analyze several diseased muscles. Unfortunately, so far, the
adoptionofdifferential proteomics inpathology, despite itshigh
potential, revealed its frailty, particularly because of the
frequent use of unspecified muscles and/or of unmatched
samples. Indeed, the selection of the former and the correct
choice of the latter are fundamental requirements for identify-
ing new biomarkers. On the other hand, the current and future
development of pharmacoproteomics, by making it possible to
act onalterednodes in themuscle biochemicalmachinery, shall
allow to counteract a progressively greaternumberof secondary
pathologic consequences of genetic muscle diseases.Acknowledgements
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